RO5469754

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO5469754, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: A Single-Ascending-Dose Study of RO5469754 in Healthy Volunteers [Phase 1]